Principal Financial Group Inc Alkermes Plc. Transaction History
Principal Financial Group Inc
- $167 Billion
- Q1 2025
A detailed history of Principal Financial Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Principal Financial Group Inc holds 928,865 shares of ALKS stock, worth $29.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
928,865
Previous 899,764
3.23%
Holding current value
$29.2 Million
Previous $25.9 Million
18.53%
% of portfolio
0.02%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding ALKS
# of Institutions
385Shares Held
163MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$914 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$581 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$385 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$277 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$237 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.16B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...